Market Cap 484.97M
Revenue (ttm) 0.00
Net Income (ttm) -117.30M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.09
Volume 357,700
Avg Vol 424,030
Day's Range N/A - N/A
Shares Out 66.99M
Stochastic %K 93%
Beta -0.06
Analysts Strong Sell
Price Target $22.80

Company Profile

enGene Therapeutics Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company in Canada. The company develops genetic medicines to help patients suffering from bladder cancer. Its lead product candidate is detalimogene voraplasmid, a monotherapy for the treatment of non-muscle invasive bladder cancer (NMIBC). Its pipeline includes LEGEND, which is in Phase 2. The company was formerly known as enGene Holdings Inc. and changed its name to enGene Therapeutics Inc...

Industry: Biotechnology
Sector: Healthcare
Phone: 514 332 4888
Address:
4868 Rue Levy, Suite 220, Montreal, Canada
Newcar
Newcar May. 13 at 11:26 AM
$ENGN Agree
0 · Reply
Newcar
Newcar May. 13 at 11:26 AM
0 · Reply
Newcar
Newcar May. 13 at 11:25 AM
$ENGN It will go down again today...look at the premarket movements...manipulated
0 · Reply
LetsgoDudeszi
LetsgoDudeszi May. 13 at 9:53 AM
$ENGN May 15, 2026 (Very Near Term): enGene is scheduled to give a Plenary Presentation at the American Urological Association (AUA) meeting. This is the first chance for management to defend the data to the medical community. .. shorties want to hold until then ?
0 · Reply
saad545
saad545 May. 13 at 8:44 AM
$ENGN haha, you will burned and bled from ass , stupid short🔥
0 · Reply
Jenny858
Jenny858 May. 12 at 9:46 PM
$ENGN is a scam ,all canadian shit stocks are scams canada is not serious place . Dont buy canadian stocks all crime
0 · Reply
fantastex
fantastex May. 12 at 9:34 PM
$ENGN 3 dollars stock trading half value.
0 · Reply
InvestorNOR
InvestorNOR May. 12 at 5:40 PM
$ENGN "After dropping 90%, I am convinced it will drop another 30%. I dont have anything to back it up, I am just here to spam a channel on stocktwits because my life is seriously this bad" Nevermind that enGene have cash to operate to 2H 2028, have very low cash burn, nothing else on the pipeline and can shut down the company and pay back $3-5 which is cash they got from investors from a public offering, as in us. Thats why you are preaching at a wall and nobody takes you serious. By all means, let it drop to $1, but if it did it would be by another bad news, which is highly unlikely at this point
0 · Reply
Newcar
Newcar May. 12 at 5:08 PM
$ENGN If this week doesn't show signs of a reversal, there's a risk it could go to $1. There's something strange that doesn't convince me... I'll wait to buy.
1 · Reply
Newcar
Newcar May. 12 at 4:32 PM
$ENGN You're such a fool. Do you really think I can influence the decline in value? The value is falling because the therapy is currently failing. We'll see in the future if anything changes.
0 · Reply
Latest News on ENGN
enGene downgraded to Perform from Outperform at Oppenheimer

2026-05-08T16:22:56.000Z - 4 days ago

enGene downgraded to Perform from Outperform at Oppenheimer


enGene downgraded to Neutral from Buy at Guggenheim

2026-05-08T09:15:51.000Z - 5 days ago

enGene downgraded to Neutral from Buy at Guggenheim


enGene downgraded to Neutral from Buy at Guggenheim

2026-05-07T21:51:44.000Z - 5 days ago

enGene downgraded to Neutral from Buy at Guggenheim


enGene announces updated interim results from LEGEND cohort

2026-05-07T14:15:38.000Z - 5 days ago

enGene announces updated interim results from LEGEND cohort


enGene Therapeutics Transcript: Study result

May 7, 2026, 8:00 AM EDT - 6 days ago

enGene Therapeutics Transcript: Study result


enGene initiated with a Buy at WBB Securities

2026-04-13T11:21:48.000Z - 4 weeks ago

enGene initiated with a Buy at WBB Securities


enGene announces name change to enGene Therapeutics

2026-04-07T12:22:18.000Z - 5 weeks ago

enGene announces name change to enGene Therapeutics


enGene Announces Name Change to enGene Therapeutics Inc.

Apr 7, 2026, 8:00 AM EDT - 5 weeks ago

enGene Announces Name Change to enGene Therapeutics Inc.


enGene price target lowered to $9 from $10 at UBS

2026-03-22T14:50:06.000Z - 7 weeks ago

enGene price target lowered to $9 from $10 at UBS


enGene price target lowered to $30 from $33 at Oppenheimer

2026-03-11T11:56:47.000Z - 2 months ago

enGene price target lowered to $30 from $33 at Oppenheimer


enGene price target lowered to $27 from $30 at Guggenheim

2026-03-10T10:56:28.000Z - 2 months ago

enGene price target lowered to $27 from $30 at Guggenheim


enGene to Participate in Upcoming Investor Conferences

Feb 20, 2026, 8:00 AM EST - 2 months ago

enGene to Participate in Upcoming Investor Conferences


enGene files $400M mixed securities shelf

2026-02-19T21:36:08.000Z - 2 months ago

enGene files $400M mixed securities shelf


enGene Announces Proposed Public Offering of Common Shares

Nov 12, 2025, 4:01 PM EST - 6 months ago

enGene Announces Proposed Public Offering of Common Shares


enGene Therapeutics Transcript: Study Update

Nov 11, 2025, 8:00 AM EST - 6 months ago

enGene Therapeutics Transcript: Study Update


enGene Named a BioSpace 2026 Best Places to Work Winner

Nov 4, 2025, 1:35 PM EST - 6 months ago

enGene Named a BioSpace 2026 Best Places to Work Winner


enGene Announces $60 Million Private Placement Financing

Oct 25, 2024, 8:00 AM EDT - 1 year ago

enGene Announces $60 Million Private Placement Financing


/C O R R E C T I O N -- enGene Inc./

Apr 9, 2024, 8:56 AM EDT - 2 years ago

/C O R R E C T I O N -- enGene Inc./


enGene Announces Leadership Succession Plan

Feb 14, 2024, 6:45 AM EST - 2 years ago

enGene Announces Leadership Succession Plan


Newcar
Newcar May. 13 at 11:26 AM
$ENGN Agree
0 · Reply
Newcar
Newcar May. 13 at 11:26 AM
0 · Reply
Newcar
Newcar May. 13 at 11:25 AM
$ENGN It will go down again today...look at the premarket movements...manipulated
0 · Reply
LetsgoDudeszi
LetsgoDudeszi May. 13 at 9:53 AM
$ENGN May 15, 2026 (Very Near Term): enGene is scheduled to give a Plenary Presentation at the American Urological Association (AUA) meeting. This is the first chance for management to defend the data to the medical community. .. shorties want to hold until then ?
0 · Reply
saad545
saad545 May. 13 at 8:44 AM
$ENGN haha, you will burned and bled from ass , stupid short🔥
0 · Reply
Jenny858
Jenny858 May. 12 at 9:46 PM
$ENGN is a scam ,all canadian shit stocks are scams canada is not serious place . Dont buy canadian stocks all crime
0 · Reply
fantastex
fantastex May. 12 at 9:34 PM
$ENGN 3 dollars stock trading half value.
0 · Reply
InvestorNOR
InvestorNOR May. 12 at 5:40 PM
$ENGN "After dropping 90%, I am convinced it will drop another 30%. I dont have anything to back it up, I am just here to spam a channel on stocktwits because my life is seriously this bad" Nevermind that enGene have cash to operate to 2H 2028, have very low cash burn, nothing else on the pipeline and can shut down the company and pay back $3-5 which is cash they got from investors from a public offering, as in us. Thats why you are preaching at a wall and nobody takes you serious. By all means, let it drop to $1, but if it did it would be by another bad news, which is highly unlikely at this point
0 · Reply
Newcar
Newcar May. 12 at 5:08 PM
$ENGN If this week doesn't show signs of a reversal, there's a risk it could go to $1. There's something strange that doesn't convince me... I'll wait to buy.
1 · Reply
Newcar
Newcar May. 12 at 4:32 PM
$ENGN You're such a fool. Do you really think I can influence the decline in value? The value is falling because the therapy is currently failing. We'll see in the future if anything changes.
0 · Reply
Newcar
Newcar May. 12 at 4:29 PM
$ENGN we will see at 1,30-1,35$👍
0 · Reply
InvestorNOR
InvestorNOR May. 12 at 4:19 PM
$ENGN everyone do yourself a favor and block Newcar. A clown who spend every single day to spam this website to spread fear 💩
0 · Reply
Newcar
Newcar May. 12 at 3:35 PM
$ENGN are they trying to bring it to $1?🤔
0 · Reply
David_M_
David_M_ May. 12 at 1:58 PM
0 · Reply
BluntForceOptions
BluntForceOptions May. 12 at 12:44 PM
$ENGN Added to the enGene long in the 1.46–1.48 range. Now around 40% allocated as this bottoming process materializes. Post-print price action is pretty typical and doing exactly what I expected... flushing out emotional hands while the valuation sits at a massive discount to the ~$3.75 adjusted net cash floor. Bottoms are a process, not an event. Sticking to the plan and building methodically into the recent flush.
0 · Reply
Jenny858
Jenny858 May. 12 at 8:24 AM
$ENGN On the nasdaq are canadian and chines son of bitches,they want our money,they short the stocks its a big crime on the fucking Nasdaq . Don't buy fucking Nasdaq stocks all fucking criminal bastards
0 · Reply
Gunnar1
Gunnar1 May. 12 at 5:13 AM
$ENGN Slowly adding, little by little...
1 · Reply
LouKojak
LouKojak May. 12 at 4:49 AM
$ENGN I'm sorry that you're an idiot 😕
1 · Reply
MarketHounds
MarketHounds May. 12 at 2:04 AM
$ENGN yup. See you soon here!
0 · Reply
ALag77
ALag77 May. 11 at 10:30 PM
$ENGN People here insult people all the time. Do you need a participation trophy for 'guessing' what something might do? Seriously, we all buy, we short, we TAKE chances. I jumped in @ $1.46 today to SEE what happens. There's no stock fortune tellers lurking around....hate to break it to ya ✌️
0 · Reply
InvestorNOR
InvestorNOR May. 11 at 9:01 PM
$ENGN Classic accumulation chart today
2 · Reply
Riddy93
Riddy93 May. 11 at 8:30 PM
$ENGN Is this the bottom
1 · Reply